Madison Avenue Partners’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,142,640
Closed -$10.2M 29
2025
Q1
$10.2M Buy
+4,142,640
New +$9.85M 0.87% 14

Other funds holding SLRN

Madison Avenue Partners's SLRN Position: Q2 2025 in Review

Madison Avenue Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 4,142,640 shares — an estimated $10.2M sold.

Madison Avenue Partners first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $10.2M in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Madison Avenue Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Madison Avenue Partners sold 4,142,640 ACELYRIN shares in Q2 2025, an estimated $10.2M.
  • Madison Avenue Partners first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
  • Madison Avenue Partners's ACELYRIN position peaked at $10.2M in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Madison Avenue Partners's 13F filing for Q2 2025, filed 14 Aug 2025.